Stock Analiz

LifeMD, Inc. (LFMD) stock forecast and price target

Price $2.19 · data as of November 13, 2026

12-month price target

Average target$6.88
Upside / downside+213.2%
Analysts8
ConsensusStrong buy
Low $3.00Average $6.88High $9.00

Gold marker: average target · white marker: today’s price ($2.19)

Analyst ratings

Strong buy 0Buy 7Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.34−332.1%$189M
Next fiscal year
ends December 31, 2027
$0.15+145.6%$236M
Next quarter
ends December 31, 2026
$-0.07−232.0%$51M
Quarter after
ends March 31, 2027
$0.07+146.2%$55M

Consensus of the analysts covering LifeMD, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 213.2% upside over 12 months. Our discounted cash flow model with moderate assumptions puts LifeMD’s intrinsic value about 84% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the LifeMD stock price target?

The average 12-month target from 8 analysts is $6.88, 213.2% above the current price of $2.19 Targets range from $3.00 to $9.00.

Is LifeMD a buy according to analysts?

The consensus rating is “Strong buy” (7 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is LifeMD expected to earn?

Analysts expect EPS of $-0.34 for the fiscal year ending December 31, 2026 and $0.15 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.